Authors





Farhad Zangeneh, MD

Latest:

Previously Unrecognized Trends in Diabetes Consumption Clusters in Medicare

Medicare beneficiaries with diabetes who are at the lowest levels of healthcare consumption often become some of the highest level consumers in subsequent years.


C. Ron Cantrell, PhD

Latest:

Costs of Asthma Among US Working Adults

Among a working population, patients with asthma experienced significantly higher direct medical costs and modestly higher work loss than patients without asthma.


M. Rashell Young, MBA, MPH

Latest:

Is Integration in Large Medical Groups Associated With Quality?

Integrated care systems allegedly provide better care. This study of 97 large medical groups nationally provides suggestive evidence that this may be true.


Katlyn Blackstone, MS, LSW

Latest:

Simply Delivered Meals: A Tale of Collaboration

Offering a meal delivery service to patients in a community-based care transition program was associated with cost savings and a 38% lower 30-day hospital readmission rate.



Hsiu-Yun Lo, PhD

Latest:

Using Financial Incentives to Improve the Care of Tuberculosis Patients

Patients enrolled in the tuberculosis pay-for-performance program received more comprehensive ambulatory care with slightly lower costs and a higher treatment success rate.




David J. Muzina, MD

Latest:

Adjunctive Aripiprazole for Depression: Predictive Value of Early Assessment

In treatment of depression with adjunctive aripiprazole, early improvement (week 2) was a significant predictor of remission, and lack of improvement was associated with nonremission.


Hara, BA

Latest:

Effective Care Management by Next Generation Accountable Care Organizations

A complex care management program implemented at 5 Next Generation accountable care organizations reduced all-cause inpatient admissions and total medical expenditures for participating beneficiaries.


Jose Alvir, DrPH

Latest:

Healthcare Utilization and Cost Effects of Prior Authorization for Pregabalin in Commercial Health Plans

Prior authorization for pregabalin in commercial insurance plans accomplished the objective of lower pregabalin utilization; however, there was no significant decrease in disease-related healthcare costs.





V. Silverstein, MD

Latest:

Novel Approaches for the Prevention and Treatment of Inflammatory Bone Loss

Current novel therapeutics for the prevention and treatment of bone loss in patients with inflammatory joint disease target cytokines and other inflammatory mediators. Mesenchymal stem cell therapy is a compelling new treatment currently being studied in clinical trials.




Zarina Sharalaya, MD

Latest:

Patients Discharged From the Emergency Department After Referral for Hospitalist Admission

Hospitalization is costly and associated with the potential for adverse medical events. Hospitalists are uniquely positioned to help avoid unnecessary emergency department admissions through consultation.




V&eacute

Latest:

Agreement Between Patient-reported Symptoms and Their Documentation in the Medical Record

Effective use of electronic medical record technology requires examination of the communication approaches of both care providers and patients.


Kathleen M. Fox, MHS, PhD

Latest:

Metastatic Non–Small Cell Lung Cancer: Costs Associated With Disease Progression

The incremental cost of disease progression among patients with metastatic stage IIIB or IV non-small cell lung cancer versus those without progression was $12,327 for 3 postprogression months.



Rowena J. Dolor, MD, MHS

Latest:

Patient Safety-Focused Medication Therapy Management: Challenges Affecting Future Implementation

Lessons learned from implementation of a pharmacist-delivered medication therapy management intervention in primary care can inform future studies and be adopted into real-world clinical settings.




AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo